- Latest week
- 17 Jul 2026
- Close
- 20736.240234
- Fair value
- 15057.947782
- Next-week expectancy
- Undecided 51.57%
LLY Chart Pack
Eli Lilly and Company
Chart Summary
Over the latest 12 completed weeks ending 2026-07-17, LLY rose 26.87%, moving from 16,345.09 to 20,736.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 18.32 and has improved across the 12-week window. Market Dynamics is 1.10 on the latest week. Next-week expectancy is undecided at 51.57% based on similar historical setup states.
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 20,736.24
- 12-Week Change
- 26.87%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 51.57%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 18.32
- Market Dynamics
- 1.10
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 17 Jul 2026
- Latest Close
- 20,736.24
- 12-Week Change
- 26.87%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 51.57%
- Signal Weeks
- 3 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 18.32
- Market Dynamics
- 1.10
Over the latest 12 completed weeks ending 2026-07-17, LLY rose 26.87%, moving from 16,345.09 to 20,736.24. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 3 of the last 12 weeks. Relative Strength is 18.32 and has improved across the 12-week window. Market Dynamics is 1.10 on the latest week. Next-week expectancy is undecided at 51.57% based on similar historical setup states.
Industry Peers
Mexico equities in Drug Manufacturers - General
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| BIIB Biogen Inc. | MEX | 17 Jul 2026 | 3484.00 | 3678.00 | 3484.00 | 3678.00 | 5.57% |
| GILD Gilead Sciences, Inc. | MEX | 17 Jul 2026 | 2275.00 | 2442.00 | 2275.00 | 2400.00 | 5.49% |
| MRK Merck & Co., Inc. | MEX | 17 Jul 2026 | 2164.99 | 2295.00 | 2101.00 | 2278.39 | 5.24% |
| PFE Pfizer Inc. | MEX | 17 Jul 2026 | 424.70 | 445.26 | 421.00 | 444.00 | 4.54% |
| ABBV AbbVie Inc. | MEX | 17 Jul 2026 | 4301.68 | 4567.00 | 4301.67 | 4495.00 | 4.49% |
| NVON Novo Nordisk A/S | MEX | 17 Jul 2026 | 864.00 | 901.00 | 851.00 | 889.66 | 2.97% |
| BMY Bristol-Myers Squibb Company | MEX | 17 Jul 2026 | 1025.00 | 1055.00 | 1000.00 | 1055.00 | 2.93% |
| BAYNN Bayer Aktiengesellschaft | MEX | 17 Jul 2026 | 779.00 | 779.00 | 779.00 | 779.00 | 0.00% |
| GSKN GSK plc | MEX | 17 Jul 2026 | 917.00 | 917.00 | 917.00 | 917.00 | 0.00% |
| AZN1N AstraZeneca PLC | MEX | 17 Jul 2026 | 2971.00 | 2971.00 | 2947.38 | 2947.38 | -0.80% |
| NOVOBN Novo Nordisk A/S | MEX | 17 Jul 2026 | 903.49 | 939.69 | 835.00 | 894.00 | -1.05% |
| JNJ Johnson & Johnson | MEX | 17 Jul 2026 | 4503.00 | 4517.00 | 4318.81 | 4437.00 | -1.47% |
| NVSN Novartis AG | MEX | 17 Jul 2026 | 2742.00 | 2742.00 | 2696.00 | 2696.00 | -1.68% |